| AKESO INC. O.N. |
| China |
| Gesundheit |
| KYG0146B1032 / A2P200 |
| 4RY (Frankfurt) |
| FRA:4RY, ETR:4RY, 4RY:GR |
| - |
| https://www.akesobio.com/ |
|
Akeso Inc. is a biopharmaceutical company focused on the research, development, and commercialization of innovative, therapeutic solutions for the treatment of various diseases, particularly relating to oncology and autoimmune disorders. As a key pla..
>Volltext.. |
| 8954.94 Mio. EUR |
| 8398.63 Mio. EUR |
| 446.3 Mio. EUR |
| -71.13 Mio. EUR |
| -124.67 Mio. EUR |
| -0.14 EUR |
| 666.25 Mio. EUR |
| 145.7 Mio. EUR |
| -80.4 Mio. EUR |
| 3.2 |
| 47.09% |
| -22.08% |
| - |
| - |
| - |
| - |
| AKESO |
| 15.11.26 |
|